Is NIRV.CN undervalued or overvalued?

As of 2025-03-17, the Intrinsic Value of Nirvana Life Sciences Inc (NIRV.CN) is -0.19 CAD. This NIRV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Nirvana Life Sciences Inc is -3,819.41%. This means that NIRV.CN is overvalued by 3,819.41%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-0.19 - -0.19	-0.19	-3,819.41%
P/E	0.00 - 0.00	0.00	-25.6%
DDM - Stable	(0.08) - (0.13)	(0.10)	-2153.7%
DDM - Multi	(0.06) - (0.09)	(0.07)	-1574.6%